DrugSense MAP DrugSense DrugSense

Create an account
Home  ·  Search  ·  Index  ·  Downloads  ·  DONATE  ·  Contact  ·  Log In
DrugSense
WHO WE ARE
About Us
DONATE
JOIN NOW!
Mission Statement
Contact Us
Banners
Flyers
Disclaimer
Feedback
Kudos
Recommend Us
Guest Book

ACTION
Activism Center
Voter Initiatives
Join Mail Lists
How to Newshawk

INFORMATION
Newsletter
DPR Net Media
Drug Policy Links
Alerts
DPR Downloads
Issues
Resources
Help
Questions

NEWSPAPER ARTICLES
Drug News Archive
Newspaper Directory
Bookmarks
Queue
News Bot
MAPNews Mail List
Canadian MAP
Dutch MAP
French MAP
German MAP
Published Letters
Newsfeeds
More Drug News

MEDIA CONTACTS
Instructions



MULTIMEDIA
OnAir
Audio-Visual
Books
DPR Net Media
Music
Store

COMMUNITY
MySpace
FaceBook
Twitter
Chat
Forums
Blogs
Mail Lists
MAPTalk Mail List
Surveys

FIND
Search
Help
MAP Power Search
Sitemap

More ...

DPC Services

Survey
Do you think it is a good idea to compare cannabis to alcohol, as was done by the SAFER campaign?

Yes
No
Not Sure
Don't Really Care



Results
Polls

Votes: 8894
Comments: 38

DrugSense Feedback
DrugSense Feedback
"> "> Your last name
Your first name or alias
Your email address
How did you learn of DrugSense?
Please send me the ...
Letter Writer's Style Guide
Map FAQ
Three Tips for Letter Writers
Sample Letters
We are developing a database of volunteers and will soon be able to assign the quantity, subject matter, and geography of news articles desired by each individual. If you would like to participate, please fill out the more comprehensive MAP Membership Form.
At present, MAP members receive " Focus Alerts". This is an article from a major publication selected for its general importance to the reform movement. It includes the E-mail address of the publisher and it is sent out about once a week. There is no obligation but we ask that recipients write a letter responding to this article and send it to the E-mail address provided.
Check this box to receive Focus Alerts
Check this box to receive the Drugnews-Digest
Check this box to receive the DrugSense Newsletter
Please provide any comments, suggestions or questions you may have.